Literature DB >> 24727756

First integrin inhibitor since Tysabri nears approval for IBD.

Cormac Sheridan.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24727756     DOI: 10.1038/nbt0314-205

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  Tysabri raises alarm bells on drug class.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2005-04       Impact factor: 54.908

2.  Notice of withdrawal: A novel, orally active alpha 4 integrin antagonist, AJM300 prevents the development of experimental colitis induced by adoptive transfer of IL-10 deficient CD4+ T cells in mice.

Authors: 
Journal:  J Pharmacol Exp Ther       Date:  2012-09       Impact factor: 4.030

3.  Vedolizumab as induction and maintenance therapy for ulcerative colitis.

Authors:  Brian G Feagan; Paul Rutgeerts; Bruce E Sands; Stephen Hanauer; Jean-Frédéric Colombel; William J Sandborn; Gert Van Assche; Jeffrey Axler; Hyo-Jong Kim; Silvio Danese; Irving Fox; Catherine Milch; Serap Sankoh; Tim Wyant; Jing Xu; Asit Parikh
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245

4.  The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases.

Authors:  Dulce Soler; Tobias Chapman; Li-Li Yang; Tim Wyant; Robert Egan; Eric R Fedyk
Journal:  J Pharmacol Exp Ther       Date:  2009-06-09       Impact factor: 4.030

5.  Antagonizing the α4β1 integrin, but not α4β7, inhibits leukocytic infiltration of the central nervous system in rhesus monkey experimental autoimmune encephalomyelitis.

Authors:  Krista G Haanstra; Sam O Hofman; Dave M Lopes Estêvão; Erwin L A Blezer; Jan Bauer; Li-Li Yang; Tim Wyant; Vilmos Csizmadia; Bert A 't Hart; Eric R Fedyk
Journal:  J Immunol       Date:  2013-01-30       Impact factor: 5.422

  5 in total
  3 in total

1.  Synthetic Retinoid AM80 Ameliorates Lung and Arthritic Autoimmune Responses by Inhibiting T Follicular Helper and Th17 Cell Responses.

Authors:  Debdut Naskar; Fei Teng; Krysta M Felix; C Pierce Bradley; Hsin-Jung Joyce Wu
Journal:  J Immunol       Date:  2017-01-27       Impact factor: 5.422

2.  A method for gene-based pathway analysis using genomewide association study summary statistics reveals nine new type 1 diabetes associations.

Authors:  Marina Evangelou; Deborah J Smyth; Mary D Fortune; Oliver S Burren; Neil M Walker; Hui Guo; Suna Onengut-Gumuscu; Wei-Min Chen; Patrick Concannon; Stephen S Rich; John A Todd; Chris Wallace
Journal:  Genet Epidemiol       Date:  2014-11-04       Impact factor: 2.135

3.  Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors.

Authors:  Yuya Isoda; Hirokazu Yagi; Tadashi Satoh; Mami Shibata-Koyama; Kazuhiro Masuda; Mitsuo Satoh; Koichi Kato; Shigeru Iida
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.